Matrix Metalloproteinases in Dental and Periodontal Tissues and Their Current Inhibitors: Developmental, Degradational and Pathological Aspects

Int J Mol Sci. 2022 Aug 11;23(16):8929. doi: 10.3390/ijms23168929.

Abstract

Objectives: This review article aims to describe some of the roles of Matrix metalloproteinases (MMPs) in enamel, dentine, dental caries, hybrid layer degradation, pulp and periodontal tissues, throwing light on their current inhibitors. The article addresses the potential of MMPs to serve as biomarkers with diagnostic and therapeutic value.

Design: The sections of this review discuss MMPs' involvement in developmental, remodeling, degradational and turnover aspects of dental and periodontal tissues as well as their signals in the pathogenesis, progress of different lesions and wound healing of these tissues. The literature was searched for original research articles, review articles and theses. The literature search was conducted in PubMed and MEDLINE for articles published in the last 20 years.

Results: 119 published papers, two textbooks and two doctoral theses were selected for preparing the current review.

Conclusions: MMPs are significant proteases, of evident contribution in dental and periapical tissue development, health and disease processes, with promising potential for use as diagnostic and prognostic disease biomarkers. Continuing understanding of their role in pathogenesis and progress of different dental, periapical and periodontal lesions, as well as in dentine-pulp wound healing could be a keystone to future diagnostic and therapeutic regimens.

Keywords: biomarkers; degradation dentistry; dental tissues; matrix metalloproteinase (MMP); orthodontic movement; periodontium; tissue inhibitors of metalloproteinases (TIMPs).

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Dental Caries*
  • Humans
  • Matrix Metalloproteinases / metabolism
  • Periodontium / metabolism

Substances

  • Biomarkers
  • Matrix Metalloproteinases

Grants and funding

This research received no external funding.